
Mary Mosher
Examiner (ID: 8621)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1643, 1805, 1815, 1804, 1813, 1641, 2899, 1609, 1648 |
| Total Applications | 1434 |
| Issued Applications | 907 |
| Pending Applications | 126 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1213327
[patent_doc_number] => 06705556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-03-16
[patent_title] => 'Composition and method for inducing tolerance to viral infection in aquatic animals'
[patent_app_type] => B2
[patent_app_number] => 10/115653
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15391
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/705/06705556.pdf
[firstpage_image] =>[orig_patent_app_number] => 10115653
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/115653 | Composition and method for inducing tolerance to viral infection in aquatic animals | Mar 27, 2002 | Issued |
Array
(
[id] => 1261256
[patent_doc_number] => 06664099
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-16
[patent_title] => 'Method for the preservation of viruses and mycoplasma'
[patent_app_type] => B1
[patent_app_number] => 09/980698
[patent_app_country] => US
[patent_app_date] => 2002-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5879
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/664/06664099.pdf
[firstpage_image] =>[orig_patent_app_number] => 09980698
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/980698 | Method for the preservation of viruses and mycoplasma | Mar 7, 2002 | Issued |
Array
(
[id] => 1122945
[patent_doc_number] => 06794129
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-21
[patent_title] => 'Method for measuring anti-protease resistance of HIV-2 in a patient'
[patent_app_type] => B1
[patent_app_number] => 09/980777
[patent_app_country] => US
[patent_app_date] => 2002-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5204
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/794/06794129.pdf
[firstpage_image] =>[orig_patent_app_number] => 09980777
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/980777 | Method for measuring anti-protease resistance of HIV-2 in a patient | Feb 19, 2002 | Issued |
Array
(
[id] => 6174525
[patent_doc_number] => 20020155123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Compositions and methods for inhibiting HIV infection'
[patent_app_type] => new
[patent_app_number] => 10/077480
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8928
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20020155123.pdf
[firstpage_image] =>[orig_patent_app_number] => 10077480
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/077480 | Neurokinin receptor antagonists and methods of use thereof for inhibiting HIV infection | Feb 14, 2002 | Issued |
Array
(
[id] => 6305964
[patent_doc_number] => 20020094524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Compositions and methods for inhibiting HIV infection'
[patent_app_type] => new
[patent_app_number] => 10/077507
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8913
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094524.pdf
[firstpage_image] =>[orig_patent_app_number] => 10077507
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/077507 | Compositions and methods for inhibiting HIV infection | Feb 14, 2002 | Abandoned |
Array
(
[id] => 6405896
[patent_doc_number] => 20020182639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Synthetic peptides for cartilage resorption assays'
[patent_app_type] => new
[patent_app_number] => 10/073679
[patent_app_country] => US
[patent_app_date] => 2002-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4156
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20020182639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10073679
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/073679 | Synthetic peptides of type II collagen for cartilage resorption assays | Feb 10, 2002 | Issued |
Array
(
[id] => 1285729
[patent_doc_number] => 06635285
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-10-21
[patent_title] => 'Shark cartilage extract: process of making, methods of using, and compositions thereof'
[patent_app_type] => B2
[patent_app_number] => 10/068950
[patent_app_country] => US
[patent_app_date] => 2002-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 48
[patent_no_of_words] => 23519
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/635/06635285.pdf
[firstpage_image] =>[orig_patent_app_number] => 10068950
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/068950 | Shark cartilage extract: process of making, methods of using, and compositions thereof | Feb 6, 2002 | Issued |
| 09/958654 | Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1protein | Feb 5, 2002 | Abandoned |
Array
(
[id] => 6869519
[patent_doc_number] => 20030082208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Protein having multiple antigen/epitope sequences and being immobilized'
[patent_app_type] => new
[patent_app_number] => 10/059271
[patent_app_country] => US
[patent_app_date] => 2002-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6394
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082208.pdf
[firstpage_image] =>[orig_patent_app_number] => 10059271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/059271 | Protein having multiple antigen/epitope sequences and being immobilized | Jan 30, 2002 | Abandoned |
Array
(
[id] => 6683194
[patent_doc_number] => 20030119058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Method of assaying type III collagen degradation'
[patent_app_type] => new
[patent_app_number] => 10/058124
[patent_app_country] => US
[patent_app_date] => 2002-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10811
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119058.pdf
[firstpage_image] =>[orig_patent_app_number] => 10058124
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/058124 | Method of assaying type III collagen degradation | Jan 28, 2002 | Abandoned |
Array
(
[id] => 6869832
[patent_doc_number] => 20030082521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Polypeptide inducing antibodies neutralizing HIV'
[patent_app_type] => new
[patent_app_number] => 10/040349
[patent_app_country] => US
[patent_app_date] => 2002-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7934
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082521.pdf
[firstpage_image] =>[orig_patent_app_number] => 10040349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/040349 | Polypeptide inducing antibodies neutralizing HIV | Jan 6, 2002 | Issued |
Array
(
[id] => 1022036
[patent_doc_number] => 06887977
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-03
[patent_title] => 'Methods and materials relating to CD8-tropic HIV-1'
[patent_app_type] => utility
[patent_app_number] => 10/040802
[patent_app_country] => US
[patent_app_date] => 2001-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 9151
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/887/06887977.pdf
[firstpage_image] =>[orig_patent_app_number] => 10040802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/040802 | Methods and materials relating to CD8-tropic HIV-1 | Dec 27, 2001 | Issued |
Array
(
[id] => 6262489
[patent_doc_number] => 20020188107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Component of stem bromelain'
[patent_app_type] => new
[patent_app_number] => 10/029301
[patent_app_country] => US
[patent_app_date] => 2001-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12499
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20020188107.pdf
[firstpage_image] =>[orig_patent_app_number] => 10029301
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/029301 | Component of stem bromelain | Dec 27, 2001 | Abandoned |
Array
(
[id] => 6869831
[patent_doc_number] => 20030082520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Procedure for quantitative determination of viral particles having a cholesterol-containing envelope'
[patent_app_type] => new
[patent_app_number] => 10/033041
[patent_app_country] => US
[patent_app_date] => 2001-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2750
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082520.pdf
[firstpage_image] =>[orig_patent_app_number] => 10033041
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/033041 | Procedure for quantitative determination of viral particles having a cholesterol-containing envelope | Dec 26, 2001 | Abandoned |
Array
(
[id] => 1253824
[patent_doc_number] => 06670466
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Human endogenous retrovirus in breast cancer'
[patent_app_type] => B1
[patent_app_number] => 10/018865
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 14369
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670466.pdf
[firstpage_image] =>[orig_patent_app_number] => 10018865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/018865 | Human endogenous retrovirus in breast cancer | Dec 18, 2001 | Issued |
Array
(
[id] => 6534536
[patent_doc_number] => 20020137025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Method and system for anonymously testing for a human malady'
[patent_app_type] => new
[patent_app_number] => 10/015133
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8444
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137025.pdf
[firstpage_image] =>[orig_patent_app_number] => 10015133
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/015133 | Method and system for anonymously testing for a human malady | Dec 10, 2001 | Abandoned |
Array
(
[id] => 1285445
[patent_doc_number] => 06635246
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-21
[patent_title] => 'Inactivated influenza virus vaccine for nasal or oral application'
[patent_app_type] => B1
[patent_app_number] => 09/913400
[patent_app_country] => US
[patent_app_date] => 2001-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3789
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/635/06635246.pdf
[firstpage_image] =>[orig_patent_app_number] => 09913400
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/913400 | Inactivated influenza virus vaccine for nasal or oral application | Dec 4, 2001 | Issued |
| 10/012212 | Ligands to enhance specific cellular uptake of biomolecules | Nov 29, 2001 | Abandoned |
Array
(
[id] => 1261059
[patent_doc_number] => 06664042
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-16
[patent_title] => 'Determining viral load in double negative T cells'
[patent_app_type] => B1
[patent_app_number] => 09/890010
[patent_app_country] => US
[patent_app_date] => 2001-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 28
[patent_no_of_words] => 13021
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/664/06664042.pdf
[firstpage_image] =>[orig_patent_app_number] => 09890010
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/890010 | Determining viral load in double negative T cells | Nov 22, 2001 | Issued |
Array
(
[id] => 6778192
[patent_doc_number] => 20030049273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin'
[patent_app_type] => new
[patent_app_number] => 10/050875
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 24104
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10050875
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/050875 | Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin | Nov 19, 2001 | Issued |